Hoyoung Huh, CEO, who has experience in IPO, M&A in global biotech, founded pH Pharma in 2015..licensing-in of new drug candidates from around the world, development within short-term and technology transfer strategy..
phase 2b for glaucoma treatment completed and phase 1b for Non-alcoholic steatohepatitis treatment progressed
(For more information, please refer to the link below)
http://www.biospectator.com/view/news_view.php?varAtcId=6446